Seres Therapeutics Updates Fiscal Year End
Ticker: MCRB · Form: 8-K · Filed: Apr 22, 2025 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | 8-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, fiscal-year-end, filing
TL;DR
SERES just updated its fiscal year end to 12/31. No major news, just housekeeping.
AI Summary
On April 21, 2025, Seres Therapeutics, Inc. filed an 8-K report. The filing indicates a change in the company's fiscal year end to December 31st. This is a routine administrative filing related to corporate structure and financial reporting.
Why It Matters
This filing clarifies Seres Therapeutics' reporting periods, which is important for investors tracking financial performance and for understanding the timing of future financial disclosures.
Risk Assessment
Risk Level: low — The filing is a routine administrative update regarding the company's fiscal year end and does not contain material non-public information about the company's operations or financial health.
Key Numbers
- 1231 — Fiscal Year End (Updated reporting period for financial statements.)
Key Players & Entities
- Seres Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 1231 (date) — Fiscal Year End
- April 21, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in Seres Therapeutics, Inc.'s fiscal year end to December 31st.
When was this 8-K report filed?
This 8-K report was filed on April 22, 2025, with the earliest event reported being April 21, 2025.
What is Seres Therapeutics, Inc.'s state of incorporation?
Seres Therapeutics, Inc. is incorporated in Delaware.
What is the new fiscal year end for Seres Therapeutics, Inc.?
The new fiscal year end for Seres Therapeutics, Inc. is December 31st.
Does this filing indicate any changes to Seres Therapeutics' business operations?
No, this filing is an administrative update regarding the company's fiscal year end and does not indicate any changes to its business operations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding Seres Therapeutics, Inc. (MCRB).